These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7097421)

  • 1. Pseudohypoaldosteronism: severe salt wasting in infancy caused by generalized mineralocorticoid unresponsiveness.
    Savage MO; Jefferson IG; Dillon MJ; Milla PJ; Honour JW; Grant DB
    J Pediatr; 1982 Aug; 101(2):239-42. PubMed ID: 7097421
    [No Abstract]   [Full Text] [Related]  

  • 2. Generalized unresponsiveness to mineralocorticoid hormones: familial recessive pseudohypoaldosteronism due to aldosterone-receptor deficiency.
    Bosson D; Kuhnle U; Mees N; Ramet J; Vamos E; Vertongen F; Wolter R; Armanini D
    Acta Endocrinol Suppl (Copenh); 1986; 279():376-80. PubMed ID: 2946135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudohypoaldosteronism due to renal and multisystem resistance to mineralocorticoids respond differently to carbenoxolone.
    Hanukoglu A; Joy O; Steinitz M; Rosler A; Hanukoglu I
    J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):105-12. PubMed ID: 9182864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudohypoaldosteronism: multiple target organ unresponsiveness to mineralocorticoid hormones.
    Oberfield SE; Levine LS; Carey RM; Bejar R; New MI
    J Clin Endocrinol Metab; 1979 Feb; 48(2):228-34. PubMed ID: 218983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
    Fardella CE; Montero J; Mosso L
    Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects.
    Hanukoglu A
    J Clin Endocrinol Metab; 1991 Nov; 73(5):936-44. PubMed ID: 1939532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid and mineralocorticoid resistance.
    Komesaroff PA; Zennaro MC
    J Endocrinol Invest; 1995; 18(7):550-64. PubMed ID: 9221274
    [No Abstract]   [Full Text] [Related]  

  • 8. I. Measurement of sweat sodium and potassium excretion for evaluation of mineralocorticoid activity in normal subjects.
    Grandchamp A; Scherrer JR; Veyrat R; Muller AF
    Helv Med Acta; 1969 Jan; 34(5):367-85. PubMed ID: 5766168
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma 17 alpha-hydroxyprogesterone and aldosterone concentrations in infants and children with congenital adrenal hyperplasia--the role of salt-losing hormones in salt wasting.
    Holcombe JH; Keenan BS; Clayton GW
    J Pediatr; 1981 Apr; 98(4):573-5. PubMed ID: 7205484
    [No Abstract]   [Full Text] [Related]  

  • 10. Pseudohyperaldosteronism with renal tubular resistance to mineralocorticoid hormones.
    Rodriguez JA; Biglieri EG; Schambelan M
    Trans Assoc Am Physicians; 1981; 94():172-82. PubMed ID: 7046191
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe pseudohypoaldosteronism in a pair of twins not associated with hydramnios.
    Bistritzer T; Lahat E; Eshel G; Barr J; Hanukoglu A; Aladjem M
    Pediatr Nephrol; 1996 Aug; 10(4):438-41. PubMed ID: 8865238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent pseudohypoaldosteronism in a 7-year-old boy.
    Satayaviboon S; Dawgert F; Monteleone PL; Monteleone JA
    Pediatrics; 1982 Apr; 69(4):458-62. PubMed ID: 7041074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monogenic hypertension].
    Bähr V; Oelkers W; Diederich S
    Med Klin (Munich); 2003 Apr; 98(4):208-17. PubMed ID: 12715144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Na+, K(+)-ATPase activity in patients with pseudohypoaldosteronism.
    Bistritzer T; Evans S; Cotariu D; Goldberg M; Aladjem M
    Pediatr Res; 1994 Mar; 35(3):372-5. PubMed ID: 8190530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pseudohypoaldosteronism: a special form of sodium loss in infancy].
    Limbowo D; Monnens L; Wels C
    Tijdschr Kindergeneeskd; 1984 Oct; 52(5):200-4. PubMed ID: 6393425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mineralocorticoid hypertension. A new form of secondary hypertension?].
    Román O
    Rev Med Chil; 1999 May; 127(5):511-3. PubMed ID: 10451619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of salt-wasting disorders of adrenal and renal origin.
    Rösler A
    J Clin Endocrinol Metab; 1984 Oct; 59(4):689-700. PubMed ID: 6384251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndromes that Mimic an Excess of Mineralocorticoids.
    Sabbadin C; Armanini D
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):231-5. PubMed ID: 27251484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudohypoaldosteronism: persistence of hyperaldosteronism and evidence for renal tubular and intestinal responsiveness to endogenous aldosterone.
    Postel-Vinay MC; Alberti GM; Ricour C; Limal JM; Rappaport R; Royer P
    J Clin Endocrinol Metab; 1974 Dec; 39(6):1038-44. PubMed ID: 4372243
    [No Abstract]   [Full Text] [Related]  

  • 20. A system for the determination of mineralocorticoid activity by electrical potential difference measurements.
    Mauser R; Wobst E
    Biomed Eng; 1976 Nov; 11(11):383-5. PubMed ID: 990362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.